|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Serum S100B is suitable for prediction and monitoring of response to chemoimmunotherapy in metastatic malignant melanoma显示文摘 | Korse CM Bonfrer JM | 2003 | Melanoma Res2003，13，1： | 1 |
| 2 | Application of tumour markers in clinical practice 显示文摘 | Keuren JF Thomas CM Bonfrer JM | 2009 | Ned Tijdschr Geneeskd2009，153，： | 1 |
| 3 | CA125 in ovarian can cer : Europe - an Group on Tumor Markers guidelines for clinical use显示文摘 | Duly MJ Bonfrer JM Kulpa J | 2005 | Int J Gynecol Cancer2005，15，5： | 1 |
| 4 | Highly elevated serum CA125 levels in a patient with cardiac failure显示文摘 | Hopman EH Helmerhorst TJ Bonfrer JM | 1993 | Eur J Ob- stet Gvnecol Reprod Bio11993，48，： | 1 |
| 5 | lmnmnophenotypic markers to differentiate between benign and malignant melanocytic lesions显示文摘 | Keijser S Missotten GS Bonfrer JM | 2006 | Ophthalmol2006，90，： | 1 |
| 6 | CA125 in ovarian cancer: European Group on Tumor Markers guidelines for clinical use显示文摘 | Duffy MJ Bonfrer JM Kulpa J | 2005 | Int J Gynecol Cancer2005，15，5： | 1 |
| 7 | Can initial serum cyfra 21-1,SCC antigen,and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis显示文摘 | Gaanenstroom KN Kenter GG Bonfrer JM | 2000 | Gynecol Oncol2000，77，1： | 1 |
| 8 | CA125 in ovarian cancer: European Group on tumor makers guidelines for clinical use显示文摘 | Duffy MJ Bonfrer JM Kulpa J | 2005 | Int J Gynecol Cancer2005，15，5： | 1 |
| 9 | Serum neuron-specific enolase and lactate dehydrogeoase as predictors of response to chemotherapy and survival in non-small cell lung cancer显示文摘 | Zandwijk N Jassem E Bonfrer JM | 1992 | Semin Oncol1992，19，1： | 1 |
| 10 | Can initial serum cyfra 21-1,SCC antigen,and TPA levels in squamous cell cervical cancer predict lymph node metastasis or prognosis?显示文摘 | Gaarenstroom KN Kenter GG Bonfrer JM | 2000 | Gynecol Oncol2000，77，1： | 1 |
| 11 | CA125in ovarian cancer:European Group on Tumor Markers guidelines for clinical use显示文摘 | Duffy MJ Bonfrer JM Kulpa J | 2005 | Int J Gynecol Canc-er2005，15，： | 1 |
| 12 | Non-invasive diagnosis of pleural malignancies: the role of tumour markers 显示文摘 | van den Heuvel MM Korse CM Bonfrer JM et at | 2008 | Lung Cancer2008，59，3： | 1 |
| 13 | CA125 in ovarian cancer:European Group on Tumor Markers guidelines for clinical use显示文摘 | Duffy MJ Bonfrer JM Kulpa J | 2005 | Int J Gynecol Cancer2005，15，5： | 1 |
| 14 | Lycopene sup- plementation elevates circulating insulin-like growth factor binding protein-1 and -2 concentrations in persons at greater risk of colorectal cancer显示文摘 | Vrieling A Voskuil DW Bonfrer JM | 2007 | Am J Clin Nutr2007，86，5： | 1 |
| 15 | Can initial serum CYFRA 21-1 ,SCC antigen,and TPA levels in squamous cervical cancer predict lymph node metastases or prognosis 显示文摘 | Gaarenstroom KN Kenter GG Bonfrer JM | 2000 | Gynecol Oncol2000，77，1： | 1 |
| 16 | Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis?显示文摘 | Gaarenstroom KN Kenter GG Bonfrer JM | 2000 | Gynecol Oneol2000，77，1： | 1 |
| 17 | An elevated progastrinreleasing peptide level in patients with well-differentiated neuroendocrine tumours indicates a primary tumour in the lung and predicts a shorter survival显示文摘 | Korse CM Taal BG Bonfrer JM | 2011 | Ann Oncol2011，22，12： | 1 |
| 18 | Proteomics in uveal melanoma显示文摘 | Missotten GS Beijnen JH Keunen JE Bonfrer JM | 2003 | Melanoma Res2003，13，： | 1 |
| 19 | Value of Cyfra 21-1, TPA, and SCC-Ag in predieling extracervieal disease and prognosis in cervical cancer 显示文摘 | Gaarenstroom KN Bonfrer JM Korse CM et at | 1997 | Anticancer Res1997，17，4： | 1 |
| 20 | Comparison of four different assays for determination of ser um S100B显示文摘 | Smit LH Korse CM Bonfrer JM | 2005 | Int J Biol Markers2005，20，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员